import Link from "next/link";
import JsonLd from "@/components/JsonLd";

export const metadata = {
  alternates: { canonical: "/compare/bpc-157-vs-ghk-cu" },
  title: "BPC-157 vs GHK-Cu — Healing Peptide Comparison | Prof. Peptide",
  description: "BPC-157 vs GHK-Cu comparison — mechanisms, tissue targets, research evidence, and when to use each of these two tissue repair and anti-aging peptides.",
};

const rows = [
  ["Structure", "15 amino acid pentadecapeptide", "Tripeptide (a peptide made of just 3 amino acids \u2014 among the smallest signaling peptides) \u2014 Glycine-Histidine-Lysine + copper"],
  ["Origin", "Derived from human gastric juice", "Naturally occurring in human plasma, saliva, urine"],
  ["Primary Mechanism", "NO system, EGR-1 (early growth response protein 1 \u2014 a transcription factor that triggers tissue repair gene expression), growth factor upregulation", "Copper-binding (carries copper ions into cells, where copper acts as an enzymatic cofactor) gene expression modulation \u2014 affects 31%+ of tissue remodeling gene set"],
  ["Strongest Application", "Gut/GI healing, tendon repair, CNS effects", "Skin regeneration, wound healing, collagen synthesis"],
  ["Wound Healing", "Strong \u2014 accelerates healing across multiple tissue types", "Strongest \u2014 identified naturally in wound fluid, landmark collagen studies"],
  ["Skin/Anti-Aging", "Secondary", "Primary \u2014 improves skin elasticity, reduces fine lines, promotes collagen"],
  ["Gut Health", "Dominant \u2014 origin is GI biology", "Minimal specific data"],
  ["Anti-inflammatory", "Yes \u2014 via NO and cytokine normalization", "Yes \u2014 reduces TGF-\u03B2 (transforming growth factor beta \u2014 a key pro-inflammatory and tissue-remodeling signaling molecule) and TNF-\u03B1 (tumor necrosis factor alpha \u2014 a major inflammation signaling molecule) expression"],
  ["Neuroprotection", "Extensive data", "Limited"],
  ["Administration", "Typically injectable (subcutaneous)", "Injectable or topical (applied to the skin rather than injected) \u2014 copper peptide serums"],
  ["Human Trials", "Very limited", "Some \u2014 corneal healing trial, wound healing data"],
];

export default function BPC157vsGHKCuPage() {
  return (
    <>
      <JsonLd data={{"@context":"https://schema.org","@type":"Article","headline":"BPC-157 vs GHK-Cu — Healing Peptide Comparison","description":"BPC-157 vs GHK-Cu comparison — mechanisms, tissue targets, research evidence, and when to use each of these two tissue repair and anti-aging peptides.","url":"https://profpeptide.com/compare/bpc-157-vs-ghk-cu","publisher":{"@type":"Organization","name":"Prof. Peptide","url":"https://profpeptide.com"}}} />
      <JsonLd data={{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://profpeptide.com"},{"@type":"ListItem","position":2,"name":"Comparisons","item":"https://profpeptide.com/compare"},{"@type":"ListItem","position":3,"name":"BPC-157 vs GHK-Cu — Healing Peptide Comparison"}]}} />
    <div className="section max-w-4xl">
      <Link href="/compare" className="text-sm text-[#0891b2] hover:underline mb-6 inline-block">&larr; Back to Comparisons</Link>
      <h1 className="text-3xl font-bold text-[#1e2d3d] dark:text-slate-100 mb-3">BPC-157 vs GHK-Cu &mdash; Healing &amp; Tissue Repair Peptide Comparison</h1>
      <p className="text-sm text-gray-500 dark:text-slate-400 leading-relaxed mb-8 max-w-2xl">BPC-157 and GHK-Cu are both studied for tissue repair and healing, but they work through completely different mechanisms and have distinct primary applications. BPC-157 originates from gastric biology and excels in systemic tissue repair. GHK-Cu is a copper-binding tripeptide with extraordinary gene regulatory activity, primarily studied for skin, wound healing, and anti-aging.</p>

      <div className="mb-8 p-5 border border-[#0891b2]/20 bg-[#0891b2]/10 rounded-xl">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-3">Why these two are studied for completely different healing problems</h2>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          BPC-157 and GHK-Cu are both research peptides studied for tissue repair, but they target almost entirely different problems. Confusing them as substitutes leads to mismatched expectations.
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          BPC-157 (15 amino acids, derived from gastric juice) is a systemic tissue repair peptide. Its strongest evidence is in gut healing, tendon and ligament repair, and CNS protection. It works through nitric oxide signaling and EGR-1 transcription factor activation &mdash; pathways involved in growth factor release at injury sites. Researchers reach for BPC-157 when the problem is internal: a torn tendon, an ulcer, a nerve injury.
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          GHK-Cu (3 amino acids: Glycine-Histidine-Lysine, plus copper) is a skin and wound healing specialist. It&apos;s a copper-binding tripeptide that affects gene expression &mdash; specifically, it modulates roughly 31% of human gene expression related to tissue remodeling. Its strongest evidence is in skin regeneration, collagen synthesis, and topical wound healing. Researchers reach for GHK-Cu when the problem is external or skin-related: aging skin, chronic wounds, scar tissue.
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
          Their mechanisms don&apos;t compete. The two peptides are sometimes used together for comprehensive tissue repair (internal injury via BPC-157 + skin/external healing via GHK-Cu), but they&apos;re not interchangeable for any single application.
        </p>
      </div>

      <div className="overflow-x-auto mb-8">
        <table className="w-full text-sm border-collapse">
          <thead><tr className="bg-gray-50 dark:bg-[#1e293b]">
            <th className="text-left px-4 py-3 font-semibold text-gray-400 dark:text-slate-500 text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-1/4"></th>
            <th className="text-left px-4 py-3 font-semibold text-[#0891b2] text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-[37.5%]">BPC-157</th>
            <th className="text-left px-4 py-3 font-semibold text-[#0891b2] text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-[37.5%]">GHK-Cu</th>
          </tr></thead>
          <tbody>{rows.map(([label, a, b], i) => (
            <tr key={i} className={i % 2 === 0 ? "bg-white dark:bg-[#0f172a]" : "bg-gray-50/50 dark:bg-slate-800/50"}>
              <td className="px-4 py-3 font-medium text-[#1e2d3d] dark:text-slate-100 border-b border-gray-100 dark:border-slate-700">{label}</td>
              <td className="px-4 py-3 text-gray-600 dark:text-slate-300 border-b border-gray-100 dark:border-slate-700">{a}</td>
              <td className="px-4 py-3 text-gray-600 dark:text-slate-300 border-b border-gray-100 dark:border-slate-700">{b}</td>
            </tr>
          ))}</tbody>
        </table>
      </div>
      <div className="mb-8">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Which one is right for you?</h2>
        <p className="text-sm text-gray-500 dark:text-slate-400 leading-relaxed mb-4">
          Both are research peptides with different primary applications. Choice depends on whether the research target is internal tissue (BPC-157) or skin/external healing (GHK-Cu).
        </p>
        <div className="space-y-4">
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Gut healing, tendon repair, or CNS research</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              BPC-157 is the right peptide. Its strongest research base is in localized internal tissue damage. Animal studies on tendon healing, gut ulcers, and nerve recovery consistently show BPC-157&apos;s EGR-1-mediated mechanism delivers strong site-specific repair. GHK-Cu has minimal evidence for these applications.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Skin regeneration, anti-aging, or wound healing research</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              GHK-Cu is the right peptide. Its tripeptide structure allows topical absorption, making it the only research peptide with serious cosmeceutical applications. Documented effects on skin elasticity, collagen synthesis, and fine line reduction are stronger than any peptide except retinol-class compounds. Often delivered as topical serums in concentrations of 1&ndash;3%.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Comprehensive tissue repair (internal + external)</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Some research protocols use both. BPC-157 addresses internal/structural tissue damage; GHK-Cu handles skin/external healing. The combination is sometimes used for athletes recovering from surgery (internal tissue with BPC-157, scar tissue with topical GHK-Cu). Mechanisms don&apos;t overlap, so combined effects are likely additive.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Topical-only application</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              GHK-Cu is the only realistic option here. BPC-157 is poorly absorbed transdermally and is ineffective when applied topically. GHK-Cu is the only research peptide with established topical bioavailability and proven cosmeceutical effects. Standard form: copper peptide serum applied to clean skin daily.
            </p>
          </div>
        </div>
      </div>

      <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5 mb-8">
        <h2 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Bottom Line</h2>
        <p className="text-sm text-gray-600 dark:text-slate-300"><Link href="/peptides/bpc-157" className="text-[#0891b2] hover:underline">BPC-157</Link> is the broader systemic repair peptide &mdash; strongest for gut, tendons, and CNS. <Link href="/peptides/ghk-cu" className="text-[#0891b2] hover:underline">GHK-Cu</Link> is the skin and wound healing specialist &mdash; particularly valuable for topical applications and anti-aging. They don&apos;t overlap significantly and can be studied together for comprehensive tissue repair protocols.</p>
      </div>

      <div className="mb-8">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-4">FAQ</h2>
        <div className="space-y-4">
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Can I use BPC-157 topically?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              BPC-157 is poorly absorbed through skin in research models &mdash; its 15-amino-acid size and structure don&apos;t support transdermal delivery. Some commercial products market BPC-157 creams or sprays for topical use, but these have minimal supporting evidence. For BPC-157 research, subcutaneous injection is the standard route.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Is GHK-Cu effective when injected, or only topical?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Both routes show effects in research, but topical is the more common application for skin-related research. Subcutaneous GHK-Cu has been studied for systemic effects (anti-inflammatory, organ repair) but the evidence base is much thinner than for topical applications. Most serious cosmeceutical research uses topical delivery.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">How does the copper in GHK-Cu actually matter?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Copper is an essential enzymatic cofactor for several remodeling enzymes (lysyl oxidase, superoxide dismutase). The GHK tripeptide binds copper and delivers it to cells where it&apos;s needed for collagen synthesis and tissue remodeling. Without copper, the GHK fragment alone has weaker activity. This is why commercial GHK-Cu products specifically include the copper complex rather than pure GHK.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Can these be combined?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Yes, with no documented interactions. Mechanisms don&apos;t overlap (gastric biology + EGR-1 for BPC-157, gene expression modulation + collagen for GHK-Cu). Some research protocols use BPC-157 systemically and GHK-Cu topically for comprehensive tissue repair coverage.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">What&apos;s the FDA status of each?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Neither is FDA-approved for human use. The FDA classified BPC-157 as a bulk drug substance in late 2023, restricting compounding pharmacy use. GHK-Cu has different regulatory positioning &mdash; it&apos;s widely used in cosmeceutical products as a skincare ingredient (FDA regulates cosmetics differently than drugs). For peptide-form supplementation, both are sold as research peptides.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Which has better human trial data?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              GHK-Cu has more human evidence &mdash; corneal healing trials, wound healing studies, and skincare efficacy studies. BPC-157&apos;s evidence is overwhelmingly animal-based, with limited published human research. For an evidence-prioritizing researcher, GHK-Cu is the safer bet for skin applications; BPC-157 is the safer bet for internal tissue applications based on extensive animal models.
            </p>
          </div>
        </div>
      </div>

      <div className="flex gap-3 mb-8">
        <Link href="/peptides/bpc-157" className="btn-primary text-sm">BPC-157 Profile</Link>
        <Link href="/peptides/ghk-cu" className="btn-outline text-sm">GHK-Cu Profile</Link>
      </div>

      <p className="text-xs text-gray-400 dark:text-slate-500">For educational and research purposes only. Not medical advice. Not for human use.</p>
    </div>
    </>
  );
}
